LC
Lunate Capital Portfolio holdings
AUM $178M
This Quarter Return
-15.86%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$171M
AUM Growth
–
Cap. Flow
+$171M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
4
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Revolution Medicines
RVMD
|
+$77.7M |
| 2 |
SAIL
SailPoint, Inc. Common Stock
SAIL
|
+$56.3M |
| 3 |
LINE
Lineage, Inc. Common Stock
LINE
|
+$35.2M |
| 4 |
Neumora Therapeutics
NMRA
|
+$2.12M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 46.6% |
| 2 | Technology | 32.85% |
| 3 | Real Estate | 20.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Revolution Medicines
RVMD
$8.53B
| $77.7M | 45.36% |
+2,196,200
| New | +$77.7M |
|
|
SAIL
2
SailPoint, Inc. Common Stock
SAIL
$12B
| $56.3M | 32.85% |
+3,000,000
| New | +$56.3M |
|
|
LINE
3
Lineage, Inc. Common Stock
LINE
$9.67B
| $35.2M | 20.55% |
+600,000
| New | +$35.2M |
|
|
4
Neumora Therapeutics
NMRA
$249M
| $2.12M | 1.24% |
+2,124,143
| New | +$2.12M |
|